Ganoderma lucidum glmst gene, encoded protein and application thereof

CN122941690APending Publication Date: 2026-10-20INST OF MICROBIOLOGY CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611395047.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-09
Publication Date
2026-10-20

AI Technical Summary

Benefits of technology

[0011]本发明具有以下有益效果:本发明通过基因组组装获得完整的单倍型辨析基因组,对120个菌株开展泛基因组构建,泛基因组分析揭示灵芝存在大量基因存在/缺失变异进一步整合PAV-GWAS、比较转录组,共表达网络分析及遗传转化实验,鉴定到影响子实体原基形成的关键基因Glmst。实验结果表明,Glmst基因RNAi菌株会抑制灵芝的子实体形成,而Glmst基因过表达则可显著促进灵芝原基形成。因此,本发明为理解担子菌发育调控与适应性进化机制提供了新的遗传学基础,并为灵芝分子育种和功能基因挖掘提供了重要资源。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention discloses a Ganoderma lucidum Glmst This invention relates to genes, their encoded proteins, and their applications, falling under the field of genetic engineering technology. The invention obtains a complete haplotype-discriminatory genome through genome assembly, constructs pan-genomes of 120 strains, and reveals numerous gene presence / deletion variations in Ganoderma lucidum through pan-genome analysis. Further integration of PAV-GWAS, comparative transcriptomics, co-expression network analysis, and genetic transformation experiments identified key genes affecting the formation of fruiting body primordia. Glmst Experimental results show that Glmst RNAi strains inhibit the formation of fruiting bodies in Ganoderma lucidum, while Glmst Gene overexpression can significantly promote the formation of Ganoderma lucidum primordia. Therefore, this invention provides a new genetic basis for understanding the mechanisms of developmental regulation and adaptive evolution in basidiomycetes, and provides an important resource for molecular breeding and functional gene discovery in Ganoderma lucidum.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of genetic engineering technology, specifically to a type of Ganoderma lucidum. Glmst Genes and their encoded proteins and their applications. Background Technology

[0002] Macrofungi not only play a crucial role in maintaining ecosystem functions but are also important edible and medicinal resources. Studies have shown that Ganoderma lucidum contains abundant triterpenes, polysaccharides, and other active metabolites, exhibiting various pharmacological activities such as anti-tumor, immunomodulatory, antiviral, and cardiovascular protection. Therefore, Ganoderma lucidum is not only a typical representative of traditional medicinal fungi but has also become one of the most economically valuable and promising fungal resources in the modern pharmaceutical and health industry.

[0003] Macrofungi fruiting bodies are an important marker of fungal complex multicellularity and a major carrier of the economic value of edible and medicinal fungi. Their formation is finely regulated by a multi-level network of environmental signals, transcriptional regulation, cell differentiation, and metabolic reprogramming, determining not only the yield and quality of the strain but also reflecting the molecular basis of complex morphogenesis and adaptive evolution. Elucidating the genetic regulatory mechanisms of fruiting body development has become an important direction in macrofungi biology research. In Ganoderma lucidum, transcriptome analysis during developmental stages has revealed dynamic changes in amino acid metabolism, carbon metabolism, and secondary metabolic pathways, and identified hydrophobic proteins and cytochromes. P450 And multiple developmental regulatory factors, including genes related to meiosis. In addition, transcription factors... Swi6 It has been confirmed that Ganoderma lucidum (PAV) participates in mycelial growth, fruiting body development, and triterpenoid biosynthesis, and its silencing significantly inhibits primordium and fruiting body formation. However, existing studies mainly focus on expression changes and candidate gene function verification during development, revealing development-related transcriptional response characteristics rather than the genetic variation basis determining phenotypic differences. Fruiting body development, as a typical complex quantitative trait, is not only regulated by gene expression but also influenced by multiple genetic factors such as structural variations. Therefore, it is essential to construct a pan-genome of Ganoderma lucidum and reveal the evolutionary pattern of PAV, integrating PAV-GWAS, transcriptomics, and co-expression network analysis to screen key genes and molecular mechanisms related to primordium formation. This will provide a new genetic basis for understanding the developmental regulation and adaptive evolution mechanisms of basidiomycetes and offer important resources for Ganoderma lucidum molecular breeding and functional gene mining. Summary of the Invention

[0004] To address the aforementioned shortcomings of existing technologies, the objective of this invention is to provide a Ganoderma lucidum (reishi mushroom) Glmst Genes and their encoded proteins and their applications to promote the formation of Ganoderma lucidum fruiting bodies.

[0005] The technical solution of the present invention to solve the above-mentioned technical problems is as follows: A Ganoderma lucidum is provided. GlmstA gene has any of the following nucleotide sequences: (A1) The nucleotide sequence shown in SEQ ID NO.1; (A2) A nucleotide sequence encoding a protein with the same function obtained by substituting, inserting or deleting one or more bases of the nucleotide sequence shown in SEQ ID NO.1; (A3) A nucleotide sequence that has at least 80% homology with the nucleotide sequence shown in SEQ ID NO.1.

[0006] This invention provides the above-mentioned Ganoderma lucidum. Glmst The gene encodes a protein having any of the following amino acid sequences: (B1) The amino acid sequence as shown in SEQ ID NO.2; (B2) An amino acid sequence of a protein having the same function as the amino acid sequence shown in SEQ ID NO.2, obtained by substitution, insertion or deletion of one or more amino acids; (B3) An amino acid sequence having at least 80% homology with the amino acid sequence shown in SEQ ID NO.2; (B4) A fusion protein obtained by attaching a tag to the N-terminus and / or C-terminus of any of the proteins defined in (B1)-(B3).

[0007] This invention provides the above-mentioned Ganoderma lucidum. Glmst Application of genes in promoting the formation of Ganoderma lucidum fruiting bodies.

[0008] This invention provides a method for promoting the formation of Ganoderma lucidum fruiting bodies, by overexpressing the above-mentioned Ganoderma lucidum... Glmst Genes promote the formation of Ganoderma lucidum fruiting bodies.

[0009] This invention provides the application of the above-mentioned encoded protein in the preparation of a formulation that promotes the formation of Ganoderma lucidum fruiting bodies.

[0010] The present invention provides an preparation for promoting the formation of Ganoderma lucidum fruiting bodies, comprising the above-mentioned encoded protein.

[0011] This invention has the following beneficial effects: It obtains a complete haplotype-discriminating genome through genome assembly, constructs pan-genomes of 120 strains, and reveals numerous gene presence / deletion variations in Ganoderma lucidum through pan-genome analysis. Further integration of PAV-GWAS, comparative transcriptomics, co-expression network analysis, and genetic transformation experiments identified key genes affecting the formation of fruiting body primordia. Glmst Experimental results show that Glmst RNAi strains inhibit the formation of fruiting bodies in Ganoderma lucidum, while GlmstGene overexpression can significantly promote the formation of Ganoderma lucidum primordia. Therefore, this invention provides a new genetic basis for understanding the mechanisms of developmental regulation and adaptive evolution in basidiomycetes, and provides an important resource for molecular breeding and functional gene discovery in Ganoderma lucidum. Attached Figure Description

[0012] Figure 1 for Glmst Bar chart showing the relative expression levels of overexpressing RNAi strains and control strain Gl5.616; Figure 2 for Glmst The primordia formation of the overexpressing and RNAi strains and the control strain Gl5.616 on days 28 and 35 after inoculation are shown in the figure. Figure 3 Vector map of the Glgpd_target_HYG expression plasmid. Detailed Implementation

[0013] The examples given below are for illustrative purposes only and are not intended to limit the scope of the invention. Unless otherwise specified, conditions in the examples are performed under standard conditions or as recommended by the manufacturer. Reagents or instruments whose manufacturers are not specified are all commercially available products.

[0014] In the early stages of this invention, a complete haplotype-discriminatory genome of Ganoderma lucidum was obtained through genome assembly. Pan-genome construction was performed on 120 strains, and pan-genome analysis revealed a large number of presence / deletion variants (PAVs) in Ganoderma lucidum. Further integration of PAV-GWAS, comparative transcriptomics, co-expression network analysis, and genetic transformation experiments identified key genes affecting the formation of primordia in Ganoderma lucidum fruiting bodies, and named them... Glmst (The nucleotide sequence is shown in SEQ ID NO.1, and the amino acid sequence is shown in SEQ ID NO.2).

[0015] Example: Glmst Gene function verification By building Glmst Gene function was validated using gene overexpression and RNAi strains, as follows: The Glgpd_target_HYG expression plasmid preserved in this laboratory (vector map shown) was used. Figure 3 Using a vector as a backbone, the vector was linearized by double digestion with QuickCut™ BstEII and QuickCut™ SpeI. Subsequently, the vector was amplified from the genomic DNA of strain Gl5.616 (CGMCC5.616, China General Microbiological Culture Collection Center). GlmstGene sequences and RNAi sequences were obtained using the ClonExpress Ultra One-Step Cloning Kit (Vazyme, C115-01, Nanjing, China). Glmst Gene sequences and RNAi sequences were ligated into linearized vectors to construct overexpression vectors and RNA interference (RNAi) vectors, respectively. Primer sequences used for plasmid construction are shown in Table 1. (Reference: Lv Z, Zhang J, Nie M, et al. Dual geneticloci and flavonoid metabolism orchestrate fruiting body coloration in...) Flammulina filiformis The ligation product was transformed into *E. coli* DH5α competent cells using the method described in the *Journal of Advanced Research* (2025). Positive monoclonal colonies were identified by Sanger sequencing to confirm that the target fragment had been correctly inserted into the vector. In fungal transformation, protoplasts were first prepared by lysing the cell walls of strain Gl5.616 using a cell wall lysin (Guangdong Institute of Microbiology, China). Subsequently, the plasmid was introduced into the protoplasts via polyethylene glycol 4000 (PEG4000)-mediated transformation. The transformation mixture was plated on TB3 (tryptone-yeast extract-sucrose) medium. After protoplast regeneration, the plates were initially screened by covering them with CYM medium containing 50 µg / mL hygromycin. After colonies appeared, they were picked with an inoculating needle and transferred to CYM medium containing 100 µg / mL hygromycin for secondary screening. Finally, heterokaryotic transformants were screened by observing clamp ligation under a microscope.

[0016] Table 1 Primers used for plasmid construction

[0017] The Ganoderma lucidum strain to be tested was activated and cultured at a constant temperature of 25℃ in the dark for 7 days. After obtaining a highly viable and pure strain, it was further transferred to a 2cm diameter test tube containing culture medium and cultured under the same conditions. The mycelial growth rate was measured and recorded, and the formation of fruiting body primordia was photographed and recorded on day 12.

[0018] The preparation method of CYM medium is as follows: add 20g glucose, 2g tryptone, 2g yeast extract, 0.46g KH2PO4, 1g K2HPO4, 0.5g MgSO4·7H2O and 20g agar to 1L distilled water, and sterilize at 121℃ for 30 minutes.

[0019] The TB3 culture medium was prepared by adding 3g of yeast extract, 3g of casein hydrolysate, 200g of sucrose, and 20g of agar to 1L of distilled water and sterilizing under the same conditions. The substrate formula was: 50% sawdust, 30% cottonseed hulls, 19% wheat bran, 1% gypsum, and 55% moisture content.

[0020] The obtained Glmst transformants were validated by PCR amplification of the target fragment. The expression level of the transformants was detected using RT-qPCR. Primer sequences are shown in Table 2. Specifically, the selected transformants were inoculated into potato dextrose agarose solid medium lined with cellophane. When the mycelium nearly covered the plates, samples were collected and stored at -80℃. DNA was extracted using the CTAB method and validated by 1% agarose gel electrophoresis. The target gene was amplified by PCR. The total volume of the PCR reaction system was 50 μL, including: 25 μL Taq PCR Master Mix, 2 μL forward primer, 2 μL reverse primer, 2 μL template DNA, and 19 μL enzyme-free water. The PCR amplification program was as follows: 95℃ pre-denaturation for 5 min; followed by 30 cycles, including 95℃ denaturation for 30 s, 55℃ annealing for 30 s, and 72℃ extension for 1 min; and a final extension at 72℃ for 10 min. The amplified products were detected by 1% agarose gel electrophoresis and imaging analysis.

[0021] Real-time quantitative PCR (RT-qPCR) analysis was performed using the SYBR Green fluorescent dye method. Total RNA was reverse transcribed into cDNA using the TransScript All-in-One First-Strand cDNA Synthesis Kit. RT-qPCR was then performed using the cDNA as a template. The RT-qPCR reactions were performed on a BIO-RAD real-time quantitative PCR instrument, with three biological replicates and three technical replicates per sample.

[0022] Table 2 Primers used for PCR and qPCR quantitative detection

[0023] Two overexpression strains with significantly higher expression levels than the control and one RNAi strain with significantly lower expression levels than the control were obtained (see...). Figure 1 During the mycelial feeding and growth stage, Glmst The overexpressing strains showed no significant difference in growth rate compared to the control strains, while the mycelial growth rate of the RNAi strains was significantly lower than that of the control strains. After 28 days of inoculation and cultivation, Glmst All overexpressing strains formed clearly visible primordia; 35 days after inoculation, GlmstBoth overexpression transformants produced young Ganoderma lucidum, while the control strain Gl5.616 only formed small, twisted primordia. No primordia were formed in any of the RNAi strains (see...). Figure 2 ).

[0024] The above results indicate that Glmst Increased expression of [a specific ingredient] significantly promotes the formation of primordia in Ganoderma lucidum fruiting bodies, while RNAi inhibits their formation. Therefore, Glmst It has a positive regulatory effect on the formation of Ganoderma lucidum fruiting bodies and plays an important role in the formation of Ganoderma lucidum fruiting body primordia.

[0025] In this invention Glmst The nucleotide sequence of the gene and the amino acid sequence and RNAi sequence of its encoded protein are as follows: (2) Amino acid sequence: MATPEAQDAAPTPSDEDVQTFCDLLDQIKVSMSSARDIIKSLREKQSTTSELDTREGISLLSVKHHLMLSYLQSITLLTARRAIGHSLADRSAPQAPFSARDRAPRGDGAGDRVDATIEARVVLEKVKVLEGRMKYQIDKLVRIADEGASADKDIANDPLAFRPNPQALMDAAASDEEDEDGTHARAREGVYRPPKLAPMPYTEPTKKSKDKDKSARRAPLPSALARLAHLDPSQPYTESTSGLGGGAGSAHGSARARELQRMTAFEEENFTRLVMKKRDARRRELDEADIALGGTGMASGSRRRVPGVGLEDEFGDILKSVGRSRQGVVGDGYEELRRRGKKESVLVRSRARSREDGFDDMGDDGPRQRKRTRFDKEVKAAKKRASSKSSRK (SEQ ID NO.2); (3) RNAi sequence:

[0026] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A type of Ganoderma lucidum Glmst Genes, characterized by, The Ganoderma lucidum Glmst A gene has any of the following nucleotide sequences: (A1) The nucleotide sequence shown in SEQ ID NO.1; (A2) A nucleotide sequence encoding a protein with the same function obtained by substituting, inserting or deleting one or more bases of the nucleotide sequence shown in SEQ ID NO.1; (A3) A nucleotide sequence that has at least 80% homology with the nucleotide sequence shown in SEQ ID NO.

1.

2. The Ganoderma lucidum as described in claim 1 Glmst The protein encoded by the gene is characterized by, The encoded protein has any of the following amino acid sequences: (B1) The amino acid sequence as shown in SEQ ID NO.2; (B2) An amino acid sequence of a protein having the same function as the amino acid sequence shown in SEQ ID NO.2, obtained by substitution, insertion or deletion of one or more amino acids; (B3) An amino acid sequence having at least 80% homology with the amino acid sequence shown in SEQ ID NO.2; (B4) A fusion protein obtained by attaching a tag to the N-terminus and / or C-terminus of any of the proteins defined in (B1)-(B3).

3. The Ganoderma lucidum as described in claim 1 Glmst Application of genes in promoting the formation of Ganoderma lucidum fruiting bodies.

4. A method for promoting the formation of Ganoderma lucidum fruiting bodies, characterized in that, By overexpressing the Ganoderma lucidum as described in claim 1 Glmst Genes promote the formation of Ganoderma lucidum fruiting bodies.

5. The use of the encoded protein of claim 2 in the preparation of a formulation that promotes the formation of Ganoderma lucidum fruiting bodies.

6. A preparation for promoting the formation of Ganoderma lucidum fruiting bodies, characterized in that, The formulation comprises the encoded protein as described in claim 2.